World News: 13:30 GMT Thursday 6th December 2018. [SELLAS Life Sciences Group via Globe Newswire via SPi World News]
NEW YORK Dec 06 2018 GLOBE NEWSWIRE -- SELLAS Life Sciences Group Inc Nasdaq SLS SELLAS or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of can...
Globe Newswire: 13:30 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.